This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

3 days in-person. 3 days virtually.
October 24–26, 2022 | Leipzig, GermanyNovember 2–4, 2022 | Virtual

Anna Rivkin
VP, Business Development for Cardiovascular, Fibrosis, Immunology & Neuroscience at BMS


Anna Rivkin is Vice President of Business Development for Cardiovascular, Fibrosis, Immunology, and Neuroscience at Bristol Myers Squibb (BMS). In this role, Anna leads a team responsible for all business development activities supporting those four therapeutic areas including, search for new innovation, conducting due diligences, negotiations and contracting. Anna joined BMS in Business Development in 2015 and has held a variety of roles of increasing responsibility. Prior to her time at BMS, Anna was the Director of Business Development and Licensing at Merck having started her career there in Clinical Development. She holds a B.A. from Johns Hopkins University and Ph.D. from Case Western Reserve University School of Medicine.